I want to assure you that I am not planning to retire as erroneously reported in the media today. In fact, quite the opposite is true. I am becoming more deeply involved in many of the Center's issues, including the proposed reorganizations of the Office of Pharmaceutical Quality and the Office of Generic Drugs. The inaccuracy of the media has unnecessarily raised concerns among Center staff, and even among my own family. My daughter emailed me this morning to ask if I'm retiring! I continue to be fully committed to the important work CDER does and to its staff who work so diligently to protect the health of the American public.
Woodcock 相信，新药数量更多意味着更多的选择，患者可以获得更好的效果。并表示在重视药物开发的同时，FDA没有放松其安全标准。然而去年发表在Innovations in Pharmacy上的一项研究发现（详细内容），在联合国列出的禁止在世界各地使用的大约150只药物中，17%仍然在美国市场上销售。而在被美国禁止使用的药物中，只有9%在世界各地销售。
），在联合国列出的禁止在世界各地使用的大约150只药物中，17%仍然在美国市场上销售。而在被美国禁止使用的药物中，只有9%在世界各地销售。